Johnson Introduces Bipartisan Bill to Tackle Overuse and Abuse of Prior Authorization ... introduced the bipartisan Patient Access to Autoimmune Treatments Act, which limits prescription drug prior authorizations used by Medicare Advantage and stand-alone Part D plans to once per ...
Limit or curb excessive prior authorization requirements for autoimmune treatments covered by Medicare Advantage and stand-alone Part D plans.
Occurrences
Evidence
The official House press releases page lists a June 8, 2026 item: "Johnson, Lawler Introduce Bipartisan Prior Authorization Reform for Autoimmune & Blood Disorders Act."
Assessments
Johnson appears to have made a direct and serious legislative attempt: her official House press materials report that on June 8, 2026, she and Rep. Michael Lawler introduced bipartisan prior-authorization reform legislation focused on autoimmune and blood-disorder treatment coverage in Medicare Advantage and stand-alone Part D plans. That materially advances the promise, but there is no evidence here that the bill was enacted or that federal policy was changed to actually limit those requirements. Under the stated rubric, a serious attempt without the promised outcome counts as not delivered, with effort credit.